Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jul;96(1):42-51.
doi: 10.1002/ccd.28420. Epub 2019 Aug 7.

Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2)

Hiroki Watanabe  1 , Hiroki Shiomi  2 , Takeshi Morimoto  3 , Yutaka Furukawa  4 , Yoshihisa Nakagawa  5 , Kenji Ando  6 , Kazushige Kadota  7 , Junichi Tazaki  2 , Hirotoshi Watanabe  2 , Masahiro Natsuaki  8 , Kenji Minatoya  9 , Michiya Hanyu  10 , Tatsuhiko Komiya  11 , Takeshi Kimura  2 ; CREDO-Kyoto PCI/CABG registry/cohort-2 investigators
Affiliations
Observational Study

Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2)

Hiroki Watanabe et al. Catheter Cardiovasc Interv. 2020 Jul.

Abstract

Objective: To assess long-term outcomes after percutaneous coronary intervention (PCI) with drug-eluting stent only compared with coronary artery bypass grafting (CABG) in patients with triple-vessel disease.

Background: Selection between PCI and CABG is still a clinically relevant issue in the management of patients with multi-vessel coronary artery disease.

Methods: Among 15,939 patients enrolled in the CREDO-Kyoto PCI/CABG registry/cohort-2, the current study population consisted of 2,193 patients who underwent elective multi-vessel coronary revascularization including left anterior descending coronary artery (LAD) either by PCI with sirolimus-eluting stent (SES) only (N = 945) or CABG (N = 1,248).

Results: The cumulative 5-year incidence of and the adjusted risk for the primary outcome measure (a composite of all-cause death, myocardial infarction [MI], or stroke) were not significantly different between PCI and CABG groups (22.6% vs. 23.0%, p = .40, and HR: 1.13, 95%CI: 0.91-1.40, p = .26). The risk of PCI relative to CABG for all-cause death and stroke was also insignificant (HR: 1.19, 95%CI: 0.92-1.53, p = .19; HR: 0.89, 95%CI: 0.62-1.27, p = .51). The adjusted 5-year risk for MI, hospitalization for heart failure (HF), any coronary revascularization and major bleeding was significantly different between the groups (HR: 1.59, 95%CI: 1.10-2.30, p = .01; HR: 1.49, 95%CI: 1.05-2.11, p = .02; HR: 3.70, 95%CI: 2.91-4.70, p < .0001; HR: 0.18, 95%CI: 0.14-0.22, p < .0001).

Conclusions: In patients who underwent coronary revascularization for multiple vessels including LAD, PCI using SES as compared with CABG was associated with a comparable 5-year risk for death/MI/stroke as well as for mortality, but with a markedly higher risk for any coronary revascularization.

Keywords: coronary artery bypass grafting; drug-eluting stent; percutaneous coronary intervention.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
    1. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375-2384.
    1. Shiomi H, Morimoto T, Furukawa Y, et al. Comparison of five-year outcome of percutaneous coronary intervention with coronary artery bypass grafting in triple-vessel coronary artery disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG registry Cohort-2). Am J Cardiol. 2015;116:59-65.
    1. Neumann F-J, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018;2019(40):87-165.
    1. Calhoon JH, Maron DJ, Smith PK, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. J Am Coll Cardiol. 2017;69:2212-2241.

MeSH terms